202 related articles for article (PubMed ID: 38512399)
1. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M; Giacobbe DR; Agvald-Ohman C; Akova M; Alastruey-Izquierdo A; Arikan-Akdagli S; Azoulay E; Blot S; Cornely OA; Cuenca-Estrella M; de Lange DW; De Rosa FG; De Waele JJ; Dimopoulos G; Garnacho-Montero J; Hoenigl M; Kanj SS; Koehler P; Kullberg BJ; Lamoth F; Lass-Flörl C; Maertens J; Martin-Loeches I; Muñoz P; Poulakou G; Rello J; Sanguinetti M; Taccone FS; Timsit JF; Torres A; Vazquez JA; Wauters J; Asperges E; Cortegiani A; Grecchi C; Karaiskos I; Le Bihan C; Mercier T; Mortensen KL; Peghin M; Rebuffi C; Tejada S; Vena A; Zuccaro V; Scudeller L; Calandra T;
Intensive Care Med; 2024 Apr; 50(4):502-515. PubMed ID: 38512399
[TBL] [Abstract][Full Text] [Related]
2. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Bassetti M; Scudeller L; Giacobbe DR; Lamoth F; Righi E; Zuccaro V; Grecchi C; Rebuffi C; Akova M; Alastruey-Izquierdo A; Arikan-Akdagli S; Azoulay E; Blot SI; Cornely OA; Lass-Flörl C; Koehler P; Cuenca-Estrella M; de Lange DW; De Rosa FG; De Waele JJ; Dimopoulos G; Garnacho-Montero J; Hoenigl M; Kanj SS; Maertens J; Martin-Loeches I; Muñoz P; Kullberg BJ; Agvald-Ohman C; Poulakou G; Rello J; Sanguinetti M; Taccone FS; Timsit JF; Torres A; Vazquez JA; Calandra T; ; ; ;
Mycoses; 2019 Apr; 62(4):310-319. PubMed ID: 30426598
[TBL] [Abstract][Full Text] [Related]
3. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.
Bassetti M; Azoulay E; Kullberg BJ; Ruhnke M; Shoham S; Vazquez J; Giacobbe DR; Calandra T
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S121-S127. PubMed ID: 33709127
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review.
Azim A; Ahmed A
Front Cell Infect Microbiol; 2024; 14():1256158. PubMed ID: 38505289
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
6. Defining Galactomannan Positivity in the Updated EORTC/MSGERC Consensus Definitions of Invasive Fungal Diseases.
Mercier T; Castagnola E; Marr KA; Wheat LJ; Verweij PE; Maertens JA
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S89-S94. PubMed ID: 33709125
[TBL] [Abstract][Full Text] [Related]
7. Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.
Giacobbe DR; Cortegiani A; Karaiskos I; Mercier T; Tejada S; Peghin M; Grecchi C; Rebuffi C; Asperges E; Zuccaro V; Scudeller L; Bassetti M;
J Fungi (Basel); 2021 Feb; 7(3):. PubMed ID: 33670864
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
[TBL] [Abstract][Full Text] [Related]
9. Defining standards of CARE for invasive fungal diseases in the ICU.
Cuenca-Estrella M; Kett DH; Wauters J
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii9-ii15. PubMed ID: 31222308
[TBL] [Abstract][Full Text] [Related]
10. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
[TBL] [Abstract][Full Text] [Related]
11. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
Shahin J; Allen EJ; Patel K; Muskett H; Harvey SE; Edgeworth J; Kibbler CC; Barnes RA; Biswas S; Soni N; Rowan KM; Harrison DA;
BMC Infect Dis; 2016 Sep; 16(1):480. PubMed ID: 27612566
[TBL] [Abstract][Full Text] [Related]
12. Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.
Alexander BD; Lamoth F; Heussel CP; Prokop CS; Desai SR; Morrissey CO; Baddley JW
Clin Infect Dis; 2021 Mar; 72(Suppl 2):S79-S88. PubMed ID: 33709131
[TBL] [Abstract][Full Text] [Related]
13. Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis.
Giacobbe DR; Asperges E; Cortegiani A; Grecchi C; Rebuffi C; Zuccaro V; Scudeller L; Bassetti M;
Mycoses; 2022 Dec; 65(12):1073-1111. PubMed ID: 35938455
[TBL] [Abstract][Full Text] [Related]
14. Invasive Fungal Infections in the Intensive Care Unit.
Ostrosky-Zeichner L; Al-Obaidi M
Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
Lum L; Lee A; Vu M; Strasser S; Davis R
Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
[TBL] [Abstract][Full Text] [Related]
16. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
Schmiedel Y; Zimmerli S
Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
[TBL] [Abstract][Full Text] [Related]
17. Serology anno 2021-fungal infections: from invasive to chronic.
Lass-Flörl C; Samardzic E; Knoll M
Clin Microbiol Infect; 2021 Sep; 27(9):1230-1241. PubMed ID: 33601011
[TBL] [Abstract][Full Text] [Related]
18. Physicians' knowledge of invasive fungal disease in China.
Chen Y; Huang X; Qiu H; Cheng L; Yu Y; Ma X; Feng S; Li Q; Wu D; Huang W; Chen D; Lv X; Hu J; Wang J; Li J; Yang W; Zhan Q; Sun B; Wang M
Mycoses; 2023 Aug; 66(8):723-731. PubMed ID: 37059587
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit.
Talento AF; Dunne K; Joyce EA; Palmer M; Johnson E; White PL; Springer J; Loeffler J; Ryan T; Collins D; Rogers TR
J Crit Care; 2017 Aug; 40():119-127. PubMed ID: 28384600
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008).
Tortorano AM; Dho G; Prigitano A; Breda G; Grancini A; Emmi V; Cavanna C; Marino G; Morero S; Ossi C; Delvecchio G; Passera M; Cusumano V; David A; Bonaccorso G; Corona A; Favaro M; Vismara C; Garau MG; Falchi S; Tejada MR;
Mycoses; 2012 Jan; 55(1):73-9. PubMed ID: 21668521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
